Skye Bioscience, Inc. Common Stock (SKYE) — Capital Reinvestment Ratio

Latest as of June 2014: 8.56x

Skye Bioscience, Inc. Common Stock (SKYE) has a Capital Reinvestment Ratio of 8.56x as of June 2014, meaning it reinvests 9% of its operating cash flow ($7.92K) in capital expenditures ($67.83K). See debt-free asset ratio of Skye Bioscience, Inc. Common Stock to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

8.56x
Capex / Operating Cash Flow

Operating Cash Flow

$7.92K
USD

Capital Expenditures

$67.83K
USD

Data as of

Jun 2014
Most recent filing

Annual Capital Reinvestment Ratio for Skye Bioscience, Inc. Common Stock (None–None)

Year-by-year Capital Reinvestment Ratio for Skye Bioscience, Inc. Common Stock from None to None. For live market cap and broader valuation context, see market value of Skye Bioscience, Inc. Common Stock.

Year Reinvestment Ratio Operating CF (USD) Capital Expenditures YoY Change
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow